SLCO1B1 and myopathy: , 22 The risk of myopathy appears to depend on the levels of a statin in the circulation, as indicated by its association with genetic variation in SLCO1B1, which encodes OATP1B1 and can reduce the transport of statins from the circulation into the liver, leading to decreased statin clearance and higher blood levels.10